Literature DB >> 18715653

Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder.

Robert K McNamara1, Ronald Jandacek, Therese Rider, Patrick Tso, Kevin E Stanford, Chang-Gyu Hahn, Neil M Richtand.   

Abstract

Previous antemortem and postmortem tissue fatty acid composition studies have observed significant deficits in the omega-3 fatty acid docosahexaenoic acid (DHA, 22:6n-3) in red blood cell (RBC) and postmortem cortical membranes of patients with unipolar depression. In the present study, we determined the fatty acid composition of postmortem orbitofrontal cortex (OFC, Brodmann area 10) of patients with bipolar disorder (n=18) and age-matched normal controls (n=19) by gas chromatography. After correction for multiple comparisons, DHA (-24%), arachidonic acid (-14%), and stearic acid (C18:0) (-4.5%) compositions were significantly lower, and cis-vaccenic acid (18:1n-7) (+12.5%) composition significantly higher, in the OFC of bipolar patients relative to normal controls. Based on metabolite:precursor ratios, significant elevations in arachidonic acid, stearic acid, and palmitic acid conversion/metabolism were observed in the OFC of bipolar patients, and were inversely correlated with DHA composition. Deficits in OFC DHA and arachidonic acid composition, and elevations in arachidonic acid metabolism, were numerically (but not significantly) greater in drug-free bipolar patients relative to patients treated with mood-stabilizer or antipsychotic medications. OFC DHA and arachidonic acid deficits were greater in patients plus normal controls with high vs. low alcohol abuse severity. These results add to a growing body of evidence implicating omega-3 fatty acid deficiency as well as the OFC in the pathoaetiology of bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715653      PMCID: PMC2620106          DOI: 10.1016/j.psychres.2007.08.021

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  73 in total

1.  Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.

Authors:  J K Yao; S Leonard; R D Reddy
Journal:  Schizophr Res       Date:  2000-03-16       Impact factor: 4.939

2.  Modulation of arachidonic acid metabolism in cultured rat astroglial cells by long-chain N-3 fatty acids.

Authors:  C Galli; F Marangoni; A Petroni
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

3.  Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder.

Authors:  H P Blumberg; E Stern; S Ricketts; D Martinez; J de Asis; T White; J Epstein; N Isenberg; P A McBride; I Kemperman; S Emmerich; V Dhawan; D Eidelberg; J H Kocsis; D A Silbersweig
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

4.  Preferential in vivo incorporation of [3H]arachidonic acid from blood in rat brain synaptosomal fractions before and after cholinergic stimulation.

Authors:  C R Jones; T Arai; J M Bell; S I Rapoport
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

5.  Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease.

Authors:  T Nakada; I L Kwee; W G Ellis
Journal:  Neuroreport       Date:  1990-10       Impact factor: 1.837

6.  Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.

Authors:  M Söderberg; C Edlund; K Kristensson; G Dallner
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

7.  Fatty acid levels in the brains of schizophrenics and normal controls.

Authors:  D F Horrobin; M S Manku; H Hillman; A Iain; M Glen
Journal:  Biol Psychiatry       Date:  1991-10-15       Impact factor: 13.382

8.  Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells.

Authors:  A Petroni; M Salami; M Blasevich; N Papini; C Galli
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

9.  Molecular species composition of glycerophospholipids from white matter of human brain.

Authors:  R Wilson; M V Bell
Journal:  Lipids       Date:  1993-01       Impact factor: 1.880

10.  Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.

Authors:  M Martinez
Journal:  Brain Res       Date:  1992-06-26       Impact factor: 3.252

View more
  54 in total

1.  Investigation of postmortem brain polyunsaturated fatty acid composition in psychiatric disorders: limitations, challenges, and future directions.

Authors:  Robert K McNamara; Ronald Jandacek
Journal:  J Psychiatr Res       Date:  2010-05-26       Impact factor: 4.791

2.  Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.

Authors:  Yewon Cheon; Jee-Young Park; Hiren R Modi; Hyung-Wook Kim; Ho-Joo Lee; Lisa Chang; Jagadeesh S Rao; Stanley I Rapoport
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

3.  Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo (1)H-MRS study.

Authors:  Robert K McNamara; Jessica Able; Ronald Jandacek; Therese Rider; Patrick Tso; Diana M Lindquist
Journal:  J Lipid Res       Date:  2008-09-18       Impact factor: 5.922

Review 4.  Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Authors:  Sabina Berretta; Stephan Heckers; Francine M Benes
Journal:  Schizophr Res       Date:  2014-11-11       Impact factor: 4.939

Review 5.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

Review 6.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

7.  First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Thomas J Blom; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Melissa P DelBello; Stephen M Strakowski
Journal:  Psychiatry Res       Date:  2015-10-09       Impact factor: 3.222

8.  Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

Authors:  Robert K McNamara; Therese Rider; Ronald Jandacek; Patrick Tso
Journal:  Psychiatry Res       Date:  2014-01-02       Impact factor: 3.222

9.  Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis.

Authors:  Robert K McNamara; Jessica A Able; Ronald Jandacek; Therese Rider; Patrick Tso
Journal:  Schizophr Res       Date:  2008-11-07       Impact factor: 4.939

10.  A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression.

Authors:  Helen M Knight; Benjamin S Pickard; Alan Maclean; Mary P Malloy; Dinesh C Soares; Allan F McRae; Alison Condie; Angela White; William Hawkins; Kevin McGhee; Margaret van Beck; Donald J MacIntyre; John M Starr; Ian J Deary; Peter M Visscher; David J Porteous; Ronald E Cannon; David St Clair; Walter J Muir; Douglas H R Blackwood
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.